| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 67 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 67 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 67 |
| 3 | PREDNISOLONE | 45 |
| 4 | PREDNISOLONE ORAL | 45 |
| 5 | PREDNISOLONE ORAL SOLUTION | 45 |
| 6 | ETOPOSIDE | 44 |
| 7 | METHOTREXATE SODIUM | 44 |
| 8 | METHOTREXATE | 37 |
| 9 | DOXORUBICIN | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARSENIC TRIOXIDE | 4 | 0.0017 |
| 1 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 2 | PURIXAN | 1 | 0.0013 |
| 3 | REPAGLINIDE | 7 | 0.0009 |
| 4 | TECLISTAMAB-CQYV | 2 | 0.0008 |
| 5 | BUSULFAN | 13 | 0.0008 |
| 6 | NARATRIPTAN | 1 | 0.0007 |
| 7 | RANOLAZINE | 7 | 0.0007 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 9 | ETOPOSIDE | 44 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glinide [EPC] | 7 | 0.0008 |
| 1 | Anti-anginal [EPC] | 7 | 0.0007 |
| 2 | Topoisomerase Inhibitor [EPC] | 44 | 0.0006 |
| 3 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 4 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Alkylating Drug [EPC] | 76 | 0.0003 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 7 | Alkaloid [EPC] | 5 | 0.0002 |
| 8 | Barbiturate [EPC] | 2 | 0.0002 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 33 | 0.0001 |